This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Conference Highlights
EAU 2018
EAU 2018 Bladder Cancer
Conferences
EAU 2018
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testis and Penile Cancer
Endourology
Press
AUA 2018
Viewing 161-180 of 364 articles
AUA 2018: Do Anterior Tumor Location and Race Predict Biochemical Outcomes for Low Risk Prostate Cancer Patients?
AUA 2018: Predictors of Organ Confined Disease in High and Very High-Risk Prostate Cancer Patients Staged with mpMRI
AUA 2018: The Impact of Blue-Light Cystoscopy on Response to Induction BCG in Patients with High-Grade Non-Muscle Invasive Bladder Cancer
AUA 2018: Which Patients with Clinically Node Positive Prostate Cancer Benefit from Radical Prostatectomy?
AUA 2018: Tips and Tricks – Open Partial Nephrectomy
AUA 2018: Debate: Molecular Subtypes: Not Ready for Prime Time
AUA 2018: Debate: Molecular Profiling Influences My Treatment Selection
AUA 2018: Treatment for MIBC for Cis-Platinum Ineligible Patients: Immediate Cystectomy
AUA 2018: Treatment for MIBC for Cis-Platinum Ineligible Patients: Other Systemic Options and Trials
AUA 2018: Using Multi-parametric Magnetic Resonance Imaging and Targeted Biopsy to Rule Out Seminal Vesicle Invasion in Prostate Cancer
AUA 2018: Correlation Between Genomic Index Lesions, Multi-parametric MRI and 68Ga-PSMA-PET/CT Imaging Features in Primary Prostate Cancer
AUA 2018: High Risk BCG Recurrent/Refractory Disease: Immediate Cystectomy
AUA 2018: Early Experience of a Randomized Controlled Trial of Radical Prostatectomy for Oligo-Metastatic Prostate Cancer: Challenges to Patient Recruitment and Effective Solutions
AUA 2018: The First Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Men Staged with mpMRI for Clinically Localized Prostate Cancer
AUA 2018: Interim Analysis of an Open Label Phase II Study of Enzalutamide and Radium-233 in Symptomatic, mCRPC
AUA 2018: Comparative Analysis of Minimally Invasive Radical and Partial Nephrectomy for Clinical T2 Renal Mass: Analysis of the Robotic Surgery for Large Renal Mass (ROSULA) Group
AUA 2018: Statin Use is Associated with Improved Prostate Cancer-Specific Outcomes in White but Not Black Men Initiating ADT
AUA 2018: Superior Efficacy of Degarelix as Neoadjuvant Hormone Therapy in Control of Acute Genitourinary Toxicity Associated with Radiation Therapy for Prostate Cancer
AUA 2018: Prognostic Impact of Bleomycin Pulmonary Toxicity on the Outcome of Patients with Testicular Cancer
AUA 2018: Factors Associated with Early Mortality and Survival Outcomes Among Patients with Testicular Neoplasms
4
5
6
7
8
9
10
11
12
13
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free